China has expanded the coverage range of 9-valent human papillomavirus (HPV) vaccinations to females aged 9 to 45 years old, up from 16 to 29, according to the National Medical Products Administration. 

Some outpatient clinics in the country already provide online booking services for HPV vaccines. There are five HPV vaccines registered for use in China, two developed domestically and three imported, that cover 2-, 4- and 9-valent HPV vaccines. 

According to data from medical services reservation platform Yuemiao, as of June 2022 the number of HPV vaccine bookings in China had surpassed 70 million, with demand exceeding supply.

Cervical cancer is the fourth most common cancer among women globally, but it can be cured if diagnosed at an early stage and treated promptly. Vaccination against HPV is a cost-effective way to reduce the risk of cancer and prevent deaths related to it. The HPV vaccines help prevent and lower the chances of cervical and other cancers. They work best if administered before exposure to HPV.

Therefore, experts recommend women get HPV vaccines as early as possible. The World Health Organization suggests vaccinating girls aged 9 to 14 years old, when most have not started sexual activity.

In addition to vaccination, experts urge all women aged 25-64 years old to receive early screening for cervical cancer.

Read More:

China to expand free HPV vaccinations supply to cover more people

China's first domestic HPV vaccine has 100% efficacy in clinical trial